Figure 1.
Survival according to Charlson comorbidity score for 2190 patients with newly diagnosed symptomatic multiple myeloma (MM) and 21,900 population controls in Denmark during the period 2005–2012.
Survival according to Charlson comorbidity score for 2190 patients with newly diagnosed symptomatic multiple myeloma (MM) and 21,900 population controls in Denmark during the period 2005–2012.